Monoclonal antibody immunotherapy in nude mice persistently infected with Cryptosporidium parvum
- PMID: 1997419
- PMCID: PMC258384
- DOI: 10.1128/iai.59.3.1172-1176.1991
Monoclonal antibody immunotherapy in nude mice persistently infected with Cryptosporidium parvum
Abstract
Three groups of congenitally athymic nude mice were persistently infected following oral administration of 2 x 10(7) Cryptosporidium parvum oocysts. Two groups were treated once daily for 10 days with either neutralizing monoclonal antibody (MAb) 17.41 or an isotype control MAb. The third group received no treatment. Intestinal-infection scores were significantly decreased in nude mice treated with MAb 17.41 compared with isotype control MAb-treated and nontreated control groups (P less than 0.005). Biliary and pancreatic cryptosporidial-infection scores were similar for the MAb 17.41-treated and isotype control MAb-treated groups (P greater than 0.05).
Similar articles
-
Immunotherapy of cryptosporidiosis in immunodeficient animal models.J Protozool. 1991 Nov-Dec;38(6):98S-100S. J Protozool. 1991. PMID: 1818225
-
Effect of orally administered monoclonal antibody on persistent Cryptosporidium parvum infection in scid mice.Infect Immun. 1993 Nov;61(11):4906-8. doi: 10.1128/iai.61.11.4906-4908.1993. Infect Immun. 1993. PMID: 8406894 Free PMC article.
-
Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice.Infect Immun. 1994 May;62(5):1927-39. doi: 10.1128/iai.62.5.1927-1939.1994. Infect Immun. 1994. PMID: 8168959 Free PMC article.
-
Molecular targets for detection and immunotherapy in Cryptosporidium parvum.Biotechnol Adv. 2007 Jan-Feb;25(1):13-44. doi: 10.1016/j.biotechadv.2006.08.003. Epub 2006 Aug 30. Biotechnol Adv. 2007. PMID: 17055210 Review.
-
Recent advances in cryptosporidiosis: the immune response.Microbes Infect. 2002 Aug;4(10):1067-80. doi: 10.1016/s1286-4579(02)01631-3. Microbes Infect. 2002. PMID: 12191657 Review.
Cited by
-
Characterization of a > 900,000-M(r) Cryptosporidium parvum sporozoite glycoprotein recognized by protective hyperimmune bovine colostral immunoglobulin.Infect Immun. 1992 Dec;60(12):5132-8. doi: 10.1128/iai.60.12.5132-5138.1992. Infect Immun. 1992. PMID: 1452347 Free PMC article.
-
Alterations in oxidative stress parameters and its associated correlation with clinical disease on experimental Cryptosporidium parvum infection in Swiss albino mice.J Parasit Dis. 2017 Sep;41(3):707-712. doi: 10.1007/s12639-016-0871-5. Epub 2016 Dec 24. J Parasit Dis. 2017. PMID: 28848264 Free PMC article.
-
Neutralization-sensitive epitopes are conserved among geographically diverse isolates of Cryptosporidium parvum.Infect Immun. 1992 Apr;60(4):1703-6. doi: 10.1128/iai.60.4.1703-1706.1992. Infect Immun. 1992. PMID: 1372299 Free PMC article.
-
Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products.Infect Immun. 2000 Jul;68(7):4117-34. doi: 10.1128/IAI.68.7.4117-4134.2000. Infect Immun. 2000. PMID: 10858229 Free PMC article.
-
Susceptibility of major histocompatibility complex (MHC) class I- and MHC class II-deficient mice to Cryptosporidium parvum infection.Infect Immun. 1994 Feb;62(2):697-9. doi: 10.1128/iai.62.2.697-699.1994. Infect Immun. 1994. PMID: 7905464 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical